Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

NCT03805477 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Bronchiolitis Obliterans Syndrome (BOS)
Bronchiolitis Obliterans (BO)

Interventions

DRUG: Nintedanib

Sponsor

University Hospital, Basel, Switzerland